Definium Therapeutics Launches Wired for Worry, a Health Care Provider Initiative to Advance the Understanding of Generalized Anxiety Disorder (GAD) Patient Impact and Neurobiology

Definium Therapeutics Inc. (DFTX) — Definium Therapeutics Inc. announced: Definium Therapeutics Launches Wired for Worry, a Health Care Provider Initiative to Advance the Understanding of Generalized Anxiety Disorder (GAD) Patient Impact and Neurobiology.

Source: Business Wire — read the full announcement there.

Browse more sector announcements in our press release archive.